Weight-loss drugs may reduce breast cancer risk by up to 30%, according to three studies, highlighting their potential role in lowering cancer development and mortality rates.

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer.…

Three studies add to evidence that jabs could be part of cancer-fighting toolkit to cut risk of developing or dying from disease